Abstract
Biofilm formation in Acinetobacter baumannii is a common cause of nosocomial infections in humans. Clinical devices and abiotic surfaces are important sites of colonization leading to formation of biofilms. Such infections are often resistant to multiple antibiotic therapies, and hence there is need for an effective mode of control. Herein, we describe the isolation, characterization of a new lytic bacteriophage of A.baumannii and its effect on biofilm. The phage AB7-IBB2, with a genome size of about 170kb was identified to be of family Podoviridae as revealed by transmission electron microscopy. It had an isometric head (35nm) and a short tail (7nm). It lysed 19/39 (49%) clinical isolates of A.baumannii. Rapid adsorption (>99% adsorbed in 4min), a latency period of 25min and a burst size 22PFU/infected cell was observed. The phage could inhibit A.baumannii biofilm formation and disrupt preformed biofilm as well. The phage has promising potential to be considered as a candidate biocontrol agent for A.baumannii infections.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
